IncabotulinumtoxinA ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01968902 (ClinicalTrials.gov)	November 2013	21/10/2013	Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients	A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis	Muscle Spasticity;Multiple Sclerosis	Biological: incabotulinumtoxinA;Biological: Placebo	Multiple Sclerosis Center of Northeastern New York	Merz North America, Inc.	Completed	18 Years	65 Years	All	27	Phase 4	United States